Show UniProt / TrEMBL protein name		View in Fasta format (DNA)		View as list

# Ureaplasma parvum serovar 3 str. ATCC 700970, ATCC 700970

>UU579 conserved hypothetical membrane lipoprotein
MKISVKKTKQIGLFTSIAIMISSVVGIGIFFKNGSIFRFNNFNEIGIIIS
WVVASLIAFFTALSFAYITFSKKSGSGIAGIIDELKAPKCARFISVLQTF
FYNGILMPSISFFAAESLLMTIIPKNSSSPQIYQIFILAIGLFLFFLLLN
FISFKFSSILQNIATIIKFIPIIAIAIIGITYGINNAQNSLFNHNNPKHA
NFSLLGILASLPSILFSFDSFLGISSLQHKIKNAQKNVPITLIVGMFLVA
IVYILITIGQVFVGEGYAYGVINKVFKNNINLLKIITIIVNVFITISIIG
VLNSFVIFSIHNAQYVINEKIIFWWSWIQRVQSKHFKEAQGLISVLFIFF
TWITIFMIISIPLNTDAYIDLLSNYPIVFFFAVYGLIIAFAFYKKVKTKQ
KIKGIKKQYYTSDVTKRPKWFFNYQNSSLKNKNILNKELKIANNWILSVW
IIGITSCLFVFLYQFLYGYTIYAWLDPYNLKLYTFGLFYANNVSVIPWIV
SLLFFVMLIFFIGFPFLNDAILNLNHKKVNKQQKVFV
>UU122 conserved hypothetical
MLGLGILVAYLSHFIRFNFLAFDFSLFTLVYLIYKVKYRFVYLVTILLSL
ANLLHGSPSWIGTMVLSLNNLFFVTMVILFKKLFIPKRPKFYLNLWVLVL
SSFLTTVFNVIMNGILYTPLYWYTFKITPTLNFLEVQKIYEKHPTLFLLN
IKSYWLGIIALYTSFNLIKNIIISFISLTILKIFADKKTIITY
>UU557 unique hypothetical membrane lipoprotein
MKKINKKIIFLSIGIVGLIPVAAIIASCARTKTTKEQNKISPYLEDGSNF
GLAMDAINTLNYVKFASLRKIVFSLVDGLIKEAPSTNSTIGNLLGISKLF
LNQYKNPVDAGFNNMTDAQLEGMRISPSYVDLSSFGINSGALAPTVSEDD
PTWVFYNNSNNRIVATKFTTNFGASKWSDGKEVNAQDFIDAIQYILDLNT
GSQLRSHLLRFNIKGTNAFNDAQEEYIRKHGVPYKNPFGRAPYILNKQTG
QWEEDPNFVPYQNQTFDKNGHPVDDLEIAAIKKAAYEIGLSTGQAYTNIS
NKELKEALKLPENKDFKFHESKTLTIFNPKYDHKKPDKNTPEKIVINLIE
NPSFNHRQKLASDDLQTLANSKDLFKFKSLPTSRFDLLMEFETYAPKPSF
SVLLTDILGNQALLPVNRRFIETHGGIEKFGSTLENFVWSGPFNIADVVL
GPQGYMTLEKNKDYFSANWTISDKIKIYFNSKNEVTSLWFEQGMISSTTV
PPSYQLKFWAQSKMRDLMKKQAGAGTVAMQFNLDRQSRYDSYQEYLKNPN
KDIPILDPDLRRAIAFAINRENILKLSGWTSSFPVTTWTSFQRIKDSKGR
NLEYWFDNKRFDSEYIDTIKDEKTHETRKQNRSFLIQNNDFSDHVAAKNS
TFENINRKDTGFDPQVAKFYLDKYKKKHPDKKQVVLKFVYPTEPADIGKA
VIAIKDLIDRNLNGYVKLELQALPPNTFVTFANSGKFDISYQNFDKYAGS
TYDSALGLFLTPDGIDLKNNKSSGYELNPTGSWTPKNFFDRYKNKAELDY
ALKRLHISEEDADIIRELVTPTNIKTSEVYNPQHLTNRADLRKLKLKDKA
IPMFDVNYSEYDAKIIHDLEHQINKLNQKIKNEPTSSSKSTWEKEANNLQ
NEIDTMQEREFYLSEEFLNKHDPKRENKPFLLVLQNNVTGQFTTLQIQPV
IDKKTNQYVQATKEDYAKYYNKENIDEINFKKRFKYKFSIKKLPIGSYQV
INLSYINDLKPLLSKYLRNENNEISDKVNNEIYMTKLETVVDQRKRIIDF
FSGNRPGWEDDDSIFRTILNLEKILRDEAAIVPIMEIDTNWTISSLGGMK
NNFTYYLQFAYDYRRPPRPGLPTSPQAEGDN
>UU273 unique hypothetical
MEQIRNLIDLQIKLKPIQKAFYDAWSKTFINGIDNNKETHEQNKKIILEI
YMILKVFLNKNRDIISKIPLNQVKKIANDILEKEIILEQPLVDYYYQSSS
CFILIPYLIQILYQSYHLNKPIYKIMCKFIIRNNLALFKEWDLIERQTLE
IIKLKTNLIEDNNKAINLFSCEQRELQHNRFVKLFNNFILVYWTKREVKY
IEAIRFLMYFIWIPIIFIVLLILILGLYFGLSNSESLKSSTQFLLDLFII
N
>UU110 conserved hypothetical membrane lipoprotein
MKINKKLLKIFAGITSLLVFIPIITACSQKSKLVVGNFDSYMDPDVANEQ
AKRFRKNNLSYSFYDNNEILSSLIKAKISDVQVASAYEVAKLAKNGLIKK
INWAKFNLKDENNQTITSIEGLKKIFTKQVWAISNAYSSYLGDLDKDGKN
DQLLEYMIPYFYQDLIFAYRGKKIPNLDDNKKDVYWSDVFKELTRNDGTP
NRFLYEQKANLGFGVDKRTPITIAKNKTKIIAIDDARTIYDIAKIMQLEG
DNKNNIIKIINHEILGIDNSISQILHILKNPNIKEDIKEENIKKLKRLQK
QLEDRQKELKTNVFLPDSSSVSYIEDKLNNISNMFKNLHPNSMYLKANSN
DVLNDLAMANVAGAIAYSGDIAFAANGGEYTTEADSNYANMKPTSDNFHV
VRPKDTMSVLDGFTISNSINKQNEQAAYEYLNELCFAGLNEKNTDGESKI
LDYGLKIHRNKTPKEIADYENSLDDQNEVGDVLEDSGYLYTPMRNFDYVQ
YSPTLNTIADYVLDENNGFYGKTGFESDLLRQKMVEIFEIDTKYKTKKER
QRKHKYISLLNEIINHIYNTYQKDKKFIFNPTLINDIYEQKPIKNLIYEC
LNNLNIKIESHVFNNYLLLKLEAIFNNINEEVEEHAALNATLRKIFNVRL
NINTLEFPTNDLSISNLKLAYLAFREKI
>UU292 conserved hypothetical
MDKKSKKILGLSVASIIAALAIIAPSTYFGLQKQEEGKKDINLDNVTRKI
PGETKDDIKVEDLNNINDQNTDLKLDFSKVSIKPQTKINYLAIGDSITAG
FNSELGWEAPGRYDPITNKISGLSFPSFIAQYINKVEPNRLASYENLGIT
GSRIEDWLYMLGAGSDEYFKNQEYRFFDFSKQMDQQKDNPFKNRLSKFFK
NFGYDSKLTPKNNHEVNINDFNGLKEQIKKANLMTITLGANDFLRYLDIP
KLVSLTNLKGNDLEIKVKEFENNLQKASLEITKNLKKLIALIRTLNSNVS
ITLVSYPLPLLRLQDVIDSSFKLTNKRRLSDEIINILNSAIKKTYDLNNN
INYIDAFDENDWKENSFNFAKAIFDIHPTELGYKRMAQDIFLKMSLGQNY
AQQKTASIANAIYDAWDSEYFNKDSDSFKQQIGFANNTNQDLVEKTLGSS
KGAAFWAKTALENDEELRKSFSNFKNTSTIVKDWLISNKRRFGSFVNLIT
SNLTSLGLDKNGYISQFLSKKDADNTNNLYKLASALASTPYIDMVISGIQ
NDLDNLDLDKNNIIGTQNISKKILYDVFRKNIINDQNLYELIKGMFHSQL
FNENKSQIKSLIKALLSDLVSSHKLLEIIFGEFATDNLKNNNEFLKNLLI
IQNKLTQTKSLDNIINVFVDALFDNDNEYLLQGPLSNVLAKIVKTNKALL
TTRIDNLFNDLFKDQTTLDATYNILIRVLGQNIPDFIKTPQASLIIKKIL
SKGTNLKLINTLKLNTIDLLTDSKTYAGIFDSSETSIINLIQKSIDFTSK
SFISDVLDLLTSDNVDLNEWKEFIKTILNSSTIKNIFNYGIVNLVSSNTT
PLKTSHFDFNVLLKNLIAVLEEKDWTTNQKTKLKSLLRMSVDELLKNPQT
QNFVTSIEDFIANKLGDLVISANNSLLKSNMSDIWKLIKEVVHDLIHSSE
SYDLIFSIINDFIDHPQNYDNLNNINDLLPLILKSTNKELQDKVDILFKK
LINNENIPNLVGTLTTNLIVKNFFVKELTVDQKQKINNFITNILPTIPNL
TLYKEIRKQAFEFLTNNINKILVDPKNTLLILNDGINKLLSNILPQLSTL
IELIDNDKIKDQDFIDVIKIFIDNLDFNKLFVNIKSNNNQTTDSTTLNQF
YFKFKLNLEPKKLIFDLIKNLLNSPILKVNDNKNNKIKIESNKAKIKSIL
TTSVTNIFENSNLMNFFNNQLSQLFSSIDLFKNLNLSNQQRLNFAKAIVE
LLNKEKLLSNLINVLITNLIDHADEYAEATDLATILSLTIKYNQNELKNA
FDKLLIGTLKNDNLQDLILRIFVKLINPNKSYDSISVVSINKLKTFISKF
ATGISKLDLYQQLKNSIFTVFSNKTKMQQLLSNDVSVINKTLLEAFNIDT
PEKVLKISSLLDINEIDARDYADIIEIILVEIGFNVTSIQNNDVNNNLKT
IDKKTNDFAFQILKKALNNGVSDQQLQKIKNVVNYLLDDIVKIHDSSSFL
RIQLEQLSHVLVDKITAVLPKSLTIKHKYTKIFSSILNNQDFLQKAKTLL
STILNELIDHKDKYKDINSFSELISVFFKNKASDLKTQLKDLLNTILKNQ
TLITNIGQVIIESFKLENKISILDSDLEQNTISFINKIFAHITELPIYTN
LVDNFFNFFSEYTKSSDTKTLNFNKFKSSLFQAIIPKISDFASLLDLFKY
NEISEQEWKSAITFFIDYLPINNLINSKILPTNSLLFVRNISISKTKPEL
NKIENIILDLFKALSQKAKTFDNNTLTKAKNIIEFTFNKLLTSNNIKNFI
NNLLSNLSPIRSFLKSINVQDKSKHNLLNM
>UU322 unique hypothetical membrane lipoprotein
MLIILMNYLKKLNNKKINYPMLKKQNKNKEQHWLEKHLRQKTGLIISWSI
IFGVLVLLSIGFGLILHFFNSNNLSIQLSFIINLNKYLVNITKILDYIGF
ALIYLPIIFLLGCWITGINGVHESLYYHVFIWLFYFISVILLIITICLSI
ATHIYY
>UU390 unique hypothetical
MNLKSFEFLKGDAIVDNQIKKAINTSLIKASFSCAIMCILVLIFGFLMRK
YLFYFSDASSLIISSRLIFQIITIIVATLSIVYFIVHLIIYFRQRNNFLA
PKFAWSIILYLLDGITMCFMISYVAAIVGLDLTLIAIGISLSIIVAMGIL
GFIMNHKIAFKLGIANIVLFTIATIGSIILLIVFFTTRYNHTGFNKGVII
ADIVLSIIWLLALSIGFASTIYIIKVMAEHHNLDNKKIMRDFTTWNSYLL
FASFNRILLYVIRLFLLFKRV
>UU502 unique hypothetical membrane lipoprotein
MSDKSTLKQENTIEYPVVGALRRASASVLDYIFISIIAFLLSLLVFINSN
FKISDIFVNNDELAPEPWRLFLMGIIAFFVYSTYYIIIPLFCKSYTLFRW
AFSIRMISLVKQNDKKILFIALIKHSLLTWLIFTIINLLAMGFCFVFADA
SFKSIQAMNETELKEYYHQIKDLKAYVQSILSLKINDNFTNTTTMAILSI
LVKSLYSIMGLVSCIIVIHMFMNSKKRALHDQVAKVVLLWMHYEKPKQAP
KHKTKREVEIQKIDNLIQELDKI
>UU507 ampL, cytosol aminopeptidase (leucine aminopeptidase)
MTLNEKKEFVYELKAVEKNHNLKGFEENTTEHVVFGGLYQKQQYLILTPD
FDSNELSRSLISFLEKSPKSVSVDLNSFLSLVPESRHASLLNVVISALEY
VEVTPFSLKSKIETKNIHNLVVDQKYHDLINKLHVIAQSQTITRTLQDTP
ANLMTPGDFEERIKELFKDLPEVKVSVLYRKDLEAKGMNAHVGVGKAAVS
DKAQPRLVVVEYNNNPETNEKYAFVGKGVCFDSGGYNVKTGSHMRWMKFD
MSGSAIVSMTVRALALNKEKVNVVAVCPLVLNLLAPEGQKPDDIVKSYNG
KTIELDNTDAEGRLILADALTYAVRDLKASKLFDVATLTGAMIYALGDTY
SGVWATNNDIWNEVVVAADYAGELVWRLPFHNDFLKMLNSNVADIANSVS
DPRGGSSRAACFLKEFTEGVPYAHFDIAITADVGHKGTGVMLRTFYRIAQ
NQKFN
>UU363 asnA, aspartate-ammonia ligase
MDQLQKAKINQTQKAIVEIKNSFQKHFAKNLNLSRVTAPLFVEGQSGLND
HLDHKQKAVSFYAKKLDKTLEIVQSLAKWKRLALLDYGFSLYEGLYTDMN
AIRADDDIDEIHSIYVDQWDWEILINNQDCNLDFLKSIVNKIYSTIRIVQ
LEIDQLYNPKQIILPDSITFISSQELEDLYPHLSPSRREYEFAKIHKAIF
IYQIGYPLKSGYIQSIRSPEYDNWNLNGDLIVYHKLNDQAIELSSMGIRV
SKQDFIKQTNFANLKNDQENNFYHQMILNNQLPQTIGGGIGQSRLCMFLL
NKKHIGEVQVSVWPNEYKDELLKKGIKLL
>UU454 nifS, nitrogen fixation protein-class-V pyridoxal-phosphate aminotransferase
MNDYKQFFPWFKNNKDVIYLDSSATSLKPQVVIDAIVDYYTKYSTNPHNT
DSNFTFHTHEIMNETRANVAKFINANFDEIIFTSGATESLNLIANGLRPH
LKKGDEIILTYIEHASNLLPWYKLRDDLGVKIIFANQKNQFPQLSDFLKV
ISPKTKVVSFASGGNLIGNVLDENLIIKNIKKIKPDVLVCVDATQSIQHR
MFDVKKCKSDFMVFSAHKLLGPTGIGVAYIKNDLIKKMQPLKYGGGMNFS
IDLNSYQLYDNYMKFEGGTPHVAGFYGFNAALKFLMDIGYNKIHEHELKI
TKYARDQLALIPEIKTYVQDATSSTITFSYNGVFCQDFANYLGSKNIIVR
SGLSCAKIINNVIQTECAIRASFYIYNDFNDVDRLIKAIKEYQKGDELNG
IL
>UU562 oppB, oligopeptide transport system permease protein
MNQKNSFEANSSQNNYGELPILNQKKRVNYSFSNNFIIFGGGRSLKTAAD
RDRVVDPLIDFFTFDSKFMTFIIKSLKLIAEFFLLAWIVITITFFLINSV
PGESALTIGITSPEAKKAILAQYGLDRPIGVRYVNYLANIFRGEFGVSTS
IRPGVEINSFIWSRYLVSFAVGIFSVLLTLVIGIPLGIFVGRKPGGILDS
VSTVIISVISAVPSLVFGLILLLIGKEVGLPFTFDINNFVTYILPGLALS
LGSIIVYVQYIKVEMNRELNSMHAKFAYLKGATVNRFVWLHALKPSLFPI
ATFFPFVILGSFVGALFIEQIFQIPGSGSLFFEAIISKDYNVILLLVIIY
SLITIIGYTIRDALYQIIDPRIRRGGK
>UU561 oppC, oligopeptide transport system permease protein
MAKFGEYLKQKSKSITSSFIDELTSDAPNKFLQPFQHQQWKIIGHLIEFR
DNAYMGGRPRPFREFANRYGRSFSGLIGLAIIIILFILAIIIPFTTGSPT
ELRPNKRYLDYFTDGFIFGTDNNGRDLWAMLWWGLRYSLGIAIIVTAIEL
VVGVTLGILMGYFEMFDKIMTFIIKILTNVPTIIILMILTIILKPSFGVM
IFAISFSGWIAMANQMRSQVKRARSFLWVAASKTLGTKAWKIILNFLPIL
IPMMITQLVFSIPGAILAESSLAFIGLSLPNTPTLGNLIADGSSIITLYP
RFTLIPSFLLVCLVASIQLVGGATQDALRRQR
>UU560 oppD, oligopeptide transport system permease protein
MKQKNNRYTYINYLRSQRAFIQTLKPQILKLTSNNVCLNEQEVDLEPQLN
NLEDINIQLTNEKVNIQDIVTLEEEINVKDNNQNQNLNEEILATTLINEQ
ASGINEISEQKETTIANKKHKKQTMAFKAANSRKNFDFEKFEKNVKYKSF
KDGTVKKIAAEIENVRLTFTNPSKPNDRALVLRNTSVQFYEGEVHAIIGE
SGSGKSVITSLLYGLAGKNANVEEGKILLYNNEVQDFSFKDWEKSRYLGK
VISAVFQNPMSTLNPTMKIGKQIMEGMLINGIVKTRKEAYNKSIEYLKLT
KINNPEEIMELYPHELSGGMIQRVVIASIVSLHPKILVLDEPTTALDPTV
QALVLDVIRELQEKFKMCIIFITHDLGVVASIANYISIMYAGQIIEEGQR
DEILWYPQHPYTWGLIMSMPDVNKGDRLATIKGSVPSRLNDIVGDAFAIR
NDYALTRDFEHEPEMYHVSETHRVKSALLDERAEKYTPPQIILDKWNNFK
KRQENN
>UU559 oppF, oligopeptide transport system permease protein
MSDTNQKKAFFNHKKRFCLPDKITIRPVTEGLIERLNANPEKKRLVQVRH
LDVTYGHGFKKFRAVKDISFNIYQGEVLGLVGESGSGKSTTGSALIGLAR
HSFGDIIIDGIKLPKQGEKVTKELTDFMVNNVQMIFQDPSNSLNPYVNIE
TVVSEGLNNIKDLKKSFLRLIYKDYLRGLKKELKAKNFLNNEQVQIFLEK
AQDLKFDYLNETAQQELIQLFNELELNHLSLDNNDEKLQKAFNDINTWKS
KTRTDITRHLILDVLKSVGLDETVLRRYPLEFSGGQQQRIGISRAVALRP
KLLIADEPISALDVSIQAQVVNIFKELKTKYDLTILFIAHDLRMVEYISD
RIAVMNKGVLLEIGPTKEIVNNFLHPYTRSLMEAVPSIDSEKKSLLGYVY
DANMHEYTPTKQPKWIHLGNDHYILGTDEEIANWKAGKY
>UU065 pepF-1, oligoendopeptidase F-zinc metalloprotease
MENKKYEWDLDDLLNNKSLDDLYAEFEEKKAKYIKAFPTFLDSKQNFAQW
QILEEEFTIVANRFYNYVSNNLNTNVVDPKWNSWSQKLSASFYELETALS
NYNSVVLANEAKIKEYLTDSQLNVYTRKYNEIFRYQPHTLNNEQSKLFST
LIRADEGFSTIFSTYTNNDMKFSDAIDAKGKKHPIKNEAEAFVHLKSKDR
VLRKSAYLSMYRAYYDSRESITKMLYYNYLSLNQQAKAKNFDDYIAKAAF
DDVVDKSLITLIYDQVKLYKDTNEDYKKVRNTYLKKLIKVSKIEPWDNGL
PLISKKIDIPIEEAKQMAIDSLSILGDEYVSNIKRAFDEKWVSWLPQKGK
RGGAYSIGGTKGISKYYILMNYTNSLRDVQTIVHELGHSMHSLYSNRTQK
IYSDYKIFYAEIASISNEVYLNYYLLEKYKNDLEMKLMILDEMISGFFAT
TTRQVIFSNFEWIANELINSGAPFTADVVMKEYQKLELEYTNKPIVEDLN
SIYSLSSITPLRIPHFYVGNFYVYKYAVGQVAAIISGHRVFTKVTGAKQK
VFDFLSSGGSKDPLDTIKLLGVDLTKPQAWQEALEIVKLWIKDYKQTIAL
LNKKRSKK
>UU521 pepF-2, oligoendopeptidase F-zinc metalloprotease
MNDINDKKYDWDIDSLLKGKKLDILFNEFVESNNELIKAFEKWINSLNDF
INFHEVSEKNLLISNRINNYVSNKLQTNLIDNEMLAWSQKIEHEQHRVAK
IFINFENLAIKNKDLINSYLKNSSLIKYQLEYEELWRYEKHILNEQQQKV
VTAISRFSSSFGDIFDVLLDSDMQYQDGINYKKQKVCFKNQTDLYVASKS
NDRALRKSAYESHFKAIYDLRNTFSKLLYYEYVKQNELAKLHNFKDYISA
DAFSDKVDKNFINHIYTQTKKFAKGINRYTKYRTLFLKQQYQLTKVEPWD
KNLDIIDKKNMFSIESAKNLTLEALALLGSEYINVVQRAFNEQWISWMPN
NNKISGAYSISNTKGLDKIFILMNYDETYNSILTLVHELGHSVHTYFANQ
SQEVYNEYETFYAEIASITNEILMNYHLLKKYENDDLMRLYILDEMISGF
IATTTRQAIFSNFEWVANEWINQGEEFSWNKIVLAYLEINHDYTGYKYNK
NKISKYDEANALILINIPHFYTGNFYVYKYVIGQICGLINAIRIFNNKAN
AKEKYFCFFKSGGSLSPLETINILDIKINENDVWEEVNIIFNSWIDDYIK
IIKKFLINKKI
>UU532 pepP, XAA-PRO aminopeptidase
MSDFKLQQVLKTIKEHEAQGADGMILFSNYNRYWFLEFASSDGFVFINKD
GKAIYLVDARYYTAASETVKNAKVILLARTPQKSTFDLLKDAMVELNITN
ALVEADYVTLDVHEMLKKLVKNTTPFTSATLRAIKTEKELEYLQKAADIA
ALTCNWIREQDIIGRTELEIATLVSKHMLELGGELNSFDPIIASGPNGGS
PHHHPGNRVIEDGDMVTVDIGCTYKGYCSDITRSFIVGNKANPQMQEIYD
KVLESQTAGINLLSTKVTGQEVDKVCRDIVDNSKFKGYFTHGTGHGVGLQ
VHELPNTNAGNPNKLPLNAVVTVEPGIYIPNVGGVRIEDTIVVKDGQALV
LTRLAYK
>UU107 potA, spermidine/putrescine transport ATP-binding protein
MEKTLLHLRDITKIYDDGFAAVNKFDLKIKKGEFVTLLGPSGCGKTTMLK
IIAGFEQPTNGKILYNGIDIKDMPIRLRPTSTVFQDYALFPNMTVKQNIK
YGLKLMRKPKDNVDQSIYLQADKVYNSASKKANEKIKELKKQRRGLLAEI
KKMDLKYQKNKNIFEIKEMRKNQYLGTLDELYQKQGINKNGKPGFLNYFK
SWFSHEKLNLNDPIDREIFNLKKAYKEKSGLDKRYDKITYKYNDLDYWES
YWATYPQLKKEQFENKNITRLLTKEEVEKEANRVINLVGLSARKDSYPSD
LSGGMQQRVALARSLVIQPEIILLDEPLSALDAKVRKQLQDELKKLHKNL
GITFILVTHDQEEALSLSDKVVVMSNGQIEQVGKPSDIYDSPNSLWVANF
IGKTNIFEGHYIAKGEVEFDGITSKTDVINGFSENEACYIMIRPEDFDVV
KKDEGSINARVESVLYKGLMWDIKCKYNDMIISVEGVNKVNEGDEIGLDW
DDIDVHVIKKDYLNNEQAI
>UU108 potB, spermidine/putrescine transport system permease
MNKQFNFNFAPSKLSDINKKNETVFFLKEVKVIKKNNRKHYKQTLFDKLK
MNKALILTIPYFLVTIFLLIIPLVSIIVKTFINNTDSTGVTTNIIDNWSV
ITPTIGMKIFNSLWIAAVATIFCLIIGYPFAYFLSIGKSKFLKAIAIALI
TSPIWMSMLVKLIGIKTFFDVVNGEINSTHGHIFTILGLVYINLPLMILP
IYTSLSTMPKNLVNASYDLGRGFFYTFFHIVIPYTKNALISGVWIVYLAA
FTSVVVSGFLNNDNAGGLIGGEIFAQGQDGISSGVQLSRSSTITLVISLI
LLGIYLIIVIIPKIVQLIYYKRKNLKKGVKNNEAD
>UU109 potC, spermidine/putrescine transport system permease
MKQINWLSWLRNFYIWIILAIIYIPLIIIVLLSFTTPSIKGNITSAFNWN
DGSNYLTLTTNQFTDALINTIIISVIAVPISTIIATITCFGVWHAKIFYK
KLMTASSQTNIMIPDVISGISLSLLFAATFIPIGFSFGFGTIILAHISSC
TPYAIMIIYPRMLKMKKNLILASYDLGYTKIATFFRIILPYLLPSIISAT
IIVFAMSFDDFIITKLVGGKVNTIGTEMYSMAKGIKAWAVCFGALMVLLT
ILIAALISANKIIKLKLINKQTNKRKLKIWNRQV
>UU193 prsA, phosphoribosylpyrophosphate synthetase
MSKNDDILLFSLSNSHQLANKIANLLKIELSPIRIDKFADGELIVAPQVP
VRGRRVIIIQSTSKPVNDSLMELLIAIDSIKRASAKAISVVIPYYGYARQ
DRKAKPREPITARLVAKMIESAGATSVLTWDIHSLQTQGFFDIPFDSLEA
VWVLMKHYFSAYKDSSNITIVSPDYGGVKRAREISIATGATLAIVDKRRS
GKNQVEINNVLGDVKDRDCVIVDDMIDTGGTILGAAKIVREKGAKSITII
ATHGLFNNNARQHFQQAIKDRIINKICIADTIENEPFDGLEIVSIAPAIA
KCIEIYSEGTGSMSFVHDENSKVLFAKKIY
>UU434 ureA, urease complex component
MNLSLREVQKLLITVAADVARRRLARGLKLNYSEAVALITDHVMEGARDG
KLVADLMQSAREVLRVDQVMEGVDTMVSIIQVEVTFPDGTKLVSVHDPIY
K
>UU433 ureB, urease complex component
MSGSSSQFSPGKLVPGAINFASGEIVMNEGREAKVISIKNTGDRPIQVGS
HFHLFEVNSALVFFDEKGNEDKERKVAYGRRFDIPSGTAIRFEPGDKKEV
SIIDLAGTREVWGVNGLVNGKLKK
>UU432 ureC, urease complex component
MFKISRKNYSDLYGITTGDSVRLGDTNLWVKVEKDLTTYGEESVFGGGKT
LREGMGMNSTMKLDDKLGNAEVMDLVITNALIVDYTGIYKADIGIKNGKI
AAIGKSGNPHLTDNVDMIVGISTEISAGEGKIYTAGGLDTHVHWLEPEIV
PVALDGGITTVIAGGTGMNDGTKATTVSPGKFWVKSALQAADGLSINAGF
LAKGQGMEDPIFEQIAAGACGLKIHEDWGATGNAIDLALTVADKTDVAVA
IHTDTLNEAGFVEHTIAAMKGRTIHAYHTEGAGGGHAPDILETVKYAHIL
PASTNPTIPYTVNTIAEHLDMLMVCHHLNPKVPEDVAFADSRIRSQTIAA
EDLLHDMGAISIMSSDTLAMGRIGEVATRTWQMAHKMKAQFGSLKGDSEF
SDNNRVKRYISKYTINPAIAHGVDSYIGSLEVGKLADIVAWEPKFFGAKP
YYVVKMGVIARCVAGDPNASIPTCEPVIMRDQFGTYGRLLTNTSVSFVSK
IGLENGIKEEYKLEKELLPVKNCRSVNKKSMKWNSATPNLEVDPQTFDAA
VDFNDLENWLEQSASELAKKLKKTSSGKYILDAEPLTEAPLAQRYFLF
>UU223 xasA, amino acid antiporter
MGFVLLTASAIIAFYTFPSLSTAGWIAIIFAFITAMCWFIPIGIAAAEMA
TIKGWAEGGIFTWVRNLLGPRNGFIVTWLQFQVTFGFVAMILFVLSSFSF
AFAGADGYNYFNTLKLGTTLNQATSVNFSKNFSNGALYGIGIVVVAGLIF
MSLLGQKRTHQFGQVALIIGILLPFFIILGFQIYTVATMPDPLYFIGKHF
QKEPHLDPSVTGTSYELNKTFMSSVVMASFMAFSFSLHGVEVSAIAANRM
DNPSKKYPQAMMIVVISALVCIIIGSIMISMTVPTSTLSFNGGLVQTIMF
NLSVGGIDVKLPDGTVAHYKTLAHAYSVIETQYGTAAANQVMYQFVYGHP
INTGSDLARSDLLTLTSEVNDPLKNPSLFISVMNIETNKMAMQGLQAITF
FIGIGVFVEVSVWMSNLSTGLNYAMRKAHFPAWVTYRLKNGSALTVAILW
IVLLMCIFAIYMFGYNSLMQYKGQTISDILANEIRINQDQKEPMALLSNQ
NLDEIKLMARSIYEHSHAPGAQANVLHFDFNKHANSEVKAIYDKIKDYIG
INAVASGTPASITNISFISNVVSQISMYYIGYNIFLIGYLRYVFKANWLR
REFRVKWSWLQISLALLAMGVNTFAVVATYLPAAPELYPGQEAYYVFISI
ALPMFICTLLLGLFIYLINYAWNKKRGINLSEHSNLTNVDQNVLDVINNW
HLYKDQKEFAKFERHVQLLQQKQVIVRTTKDKAQRELVANEMQYLAAEIA
TRFAPEEEH